{"id":"W2790257752","doi":"10.1111/cas.13550","title":"Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma","year":2018,"lang":"en","type":"article","venue":"Cancer Science","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pediatric Oncology Group","funders":"Ministry of Health, Labour and Welfare","keywords":"Dexamethasone; Bortezomib; Thalidomide; Multiple myeloma; Refractory (planetary science); Medicine; Internal medicine; Lenalidomide; Oncology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004261177,0.001814623,0.002726477,0.0007743472,0.0004159392,0.001019213,0.001192404,0.001845972,0.004760027],"category_scores_gemma":[0.002544519,0.0009278893,0.001613853,0.0005667528,0.00144401,0.0009763253,0.0005117555,0.002803504,0.0006733609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009707942,"about_ca_system_score_gemma":0.001632733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008517969,"about_ca_topic_score_gemma":0.001914894,"domain_scores_codex":[0.9983498,0.001201634,0.00008027558,0.0001324077,0.00007904482,0.0001568624],"domain_scores_gemma":[0.9977254,0.000922536,0.0004556465,0.0001493527,0.00007679846,0.0006701896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9644854,0.01844825,0.0006369601,0.0002075477,0.0003405069,0.0000336847,0.00005468359,0.0004293939,0.003095485,0.0001322246,0.0003924162,0.01174333],"study_design_scores_gemma":[0.8154964,0.1821695,0.000727407,0.00001386188,0.0001730939,0.00002450858,0.00001600209,0.0005222794,0.0003661199,0.0001340861,0.0003463115,0.00001044169],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915836,0.001607378,0.0006021182,0.0006623989,0.000568498,0.003703401,0.0003859989,0.00005919886,0.0008274287],"genre_scores_gemma":[0.9863906,0.001570612,0.002321895,0.00154847,0.000785126,0.0049956,0.0004697851,0.00002339199,0.001894595],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004760027,"threshold_uncertainty_score":0.02253556,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0825611048857459,"score_gpt":0.391696403772379,"score_spread":0.3091352988866331,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}